BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17609851)

  • 1. Lack of association of fragile histidine triad (FHIT) polymorphisms with lung cancer in the Korean population.
    Jung HY; Sung JS; Whang YM; Shin HD; Park BL; Kim JS; Shin SW; Seo HY; Sung HJ; Choi IK; Oh SC; Seo JH; Kim YH
    J Hum Genet; 2007; 52(8):668. PubMed ID: 17609851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation analysis of the FHIT gene in bronchoscopic specimens from patients with suspected lung cancer.
    Cecener G; Tunca B; Egeli U; Karadag M; Vatan O; Uzaslan E; Tolunay S
    Tumori; 2008; 94(6):845-8. PubMed ID: 19267103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of fragile histidine triad gene expression in advanced lung cancer is consequent to allelic loss at 3p14 locus and promoter methylation.
    Wali A; Srinivasan R; Shabnam MS; Majumdar S; Joshi K; Behera D
    Mol Cancer Res; 2006 Feb; 4(2):93-9. PubMed ID: 16513840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased fragile histidine triad gene messenger RNA expression in lung cancer.
    Sasaki H; Haneda H; Yukiue H; Kobayashi Y; Yano M; Fujii Y
    Clin Lung Cancer; 2006 May; 7(6):412-6. PubMed ID: 16800968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fragile histidine triad gene inactivation in lung cancer: the European Early Lung Cancer project.
    Verri C; Roz L; Conte D; Liloglou T; Livio A; Vesin A; Fabbri A; Andriani F; Brambilla C; Tavecchio L; Calarco G; CalabrĂ² E; Mancini A; Tosi D; Bossi P; Field JK; Brambilla E; Sozzi G;
    Am J Respir Crit Care Med; 2009 Mar; 179(5):396-401. PubMed ID: 19096006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fragile histidine triad gene alterations are not essential for hepatocellular carcinoma development in South Korea.
    Nam CW; Shin JW; Park NH
    World J Gastroenterol; 2008 Jun; 14(22):3526-33. PubMed ID: 18567082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations.
    Fong KM; Biesterveld EJ; Virmani A; Wistuba I; Sekido Y; Bader SA; Ahmadian M; Ong ST; Rassool FV; Zimmerman PV; Giaccone G; Gazdar AF; Minna JD
    Cancer Res; 1997 Jun; 57(11):2256-67. PubMed ID: 9187130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association study of TP53 polymorphisms with lung cancer in a Korean population.
    Jung HY; Whang YM; Sung JS; Shin HD; Park BL; Kim JS; Shin SW; Seo HY; Seo JH; Kim YH
    J Hum Genet; 2008; 53(6):508. PubMed ID: 18363031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent FHIT gene loss of heterozygosity in human papillomavirus-infected non-smoking female lung cancer in Taiwan.
    Wang J; Cheng YW; Wu DW; Chen JT; Chen CY; Chou MC; Lee H
    Cancer Lett; 2006 Apr; 235(1):18-25. PubMed ID: 15935551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precise localization of the FHIT gene to the common fragile site at 3p14.2 (FRA3B) and characterization of homozygous deletions within FRA3B that affect FHIT transcription in tumor cell lines.
    Ong ST; Fong KM; Bader SA; Minna JD; Le Beau MM; McKeithan TW; Rassool FV
    Genes Chromosomes Cancer; 1997 Sep; 20(1):16-23. PubMed ID: 9290949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homozygous deletion but not mutation of exons 5 and 8 of the fragile histidine triad (FHIT) gene is associated with features of differentiated thyroid carcinoma.
    Yin DT; Wang L; Sun J; Yin F; Yan Q; Shen RL; Gao JX; He G
    Ann Clin Lab Sci; 2010; 40(3):267-72. PubMed ID: 20689140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent allelic deletion at the FHIT locus associated with p53 overexpression in squamous cell carcinoma subtype of Taiwanese non-small-cell lung cancers.
    Lee YC; Wu CT; Shih JY; Jou YS; Chang YL
    Br J Cancer; 2004 Jun; 90(12):2378-83. PubMed ID: 15150628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of 5'-CpG island hypermethylation of the FHIT gene with lung cancer in southern-central Chinese population.
    Li W; Deng J; Jiang P; Tang J
    Cancer Biol Ther; 2010 Nov; 10(10):997-1000. PubMed ID: 20814237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5'CpG island hypermethylation and aberrant transcript splicing both contribute to the inactivation of the FHIT gene in resected non-small cell lung cancer.
    Tzao C; Tsai HY; Chen JT; Chen CY; Wang YC
    Eur J Cancer; 2004 Sep; 40(14):2175-83. PubMed ID: 15341994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrations in the fragile histidine triad(FHIT) gene may be involved in lung carcinogenesis in patients with chronic pulmonary tuberculosis.
    Song L; Yan W; Deng M; Song S; Zhang J; Zhao T
    Tumour Biol; 2004; 25(5-6):270-5. PubMed ID: 15627891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coexpression of fragile histidine triad and c-kit is relevant for prediction of survival in patients with small cell lung cancer.
    Rehfeld N; Geddert H; Atamna A; Gabbert HE; Steidl U; Fenk R; Kronenwett R; Haas R; Rohr UP
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2232-8. PubMed ID: 17119051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of FHIT function in lung cancer and preinvasive bronchial lesions.
    Sozzi G; Pastorino U; Moiraghi L; Tagliabue E; Pezzella F; Ghirelli C; Tornielli S; Sard L; Huebner K; Pierotti MA; Croce CM; Pilotti S
    Cancer Res; 1998 Nov; 58(22):5032-7. PubMed ID: 9823304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancer.
    Iliopoulos D; Guler G; Han SY; Johnston D; Druck T; McCorkell KA; Palazzo J; McCue PA; Baffa R; Huebner K
    Oncogene; 2005 Feb; 24(9):1625-33. PubMed ID: 15674328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic relevance of fragile histidine triad protein expression in patients with small cell lung cancer.
    Rohr UP; Rehfeld N; Geddert H; Pflugfelder L; Bruns I; Neukirch J; Rohrbeck A; Grote HJ; Steidl U; Fenk R; Opalka B; Gabbert HE; Kronenwett R; Haas R
    Clin Cancer Res; 2005 Jan; 11(1):180-5. PubMed ID: 15671544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Relationship between Occurrence of Liver Cancer and Methylation of Fragile Histidine Triad (FHIT) and P16 Genes.
    Bai Y; Shen Y; Yuan Q; Lv C; Xing Q
    Med Sci Monit; 2019 Feb; 25():1301-1306. PubMed ID: 30773529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.